As we reach the end of the month, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and categories on BPIQ.com compared to XBI.
Table 1. BPIQ company weekly moves and YTD moves
Highlights for the week of 2/21 - 2/25
Biggest positive move
$LNTH +61.6% Fourth Quarter and Full Year 2021 Financial Results: Worldwide revenue represented an increase of 37.6% over the prior year period
Biggest negative move
$KOD -83.2% Kodiak Sciences Announces Top-Line Results from its initial Phase 2b/3 Study of KSI-301 in Patients with Neovascular (Wet) Age-Related Macular Degeneration - did not meet primary endpoint
Additional big moves
$OCGN +22.3% Ocugen, Inc. Announces Proposed Public Offering of Common Stock
$MRNA +15.2% Moderna - EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union
$AQST +12.1% Aquestive Therapeutics Reports Positive Topline Data From Part 1 Of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film.
$ADIL +9% ADIAL PHARMACEUTICALS ANNOUNCES COMPLETION OF LAST PATIENT, LAST VISIT IN ITS ONWARD™ PHASE 3 TRIAL OF AD04 FOR THE TREATMENT OF PATIENTS WITH ALCOHOL USE DISORDER
$MRNS -12.8% Marinus Pharmaceuticals Announces Delay to RAISE Phase 3 Clinical Trial in Status Epilepticus and Associated IV Ganaxolone Clinical Trial
$RYTM -13.5% Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Bardet-Biedl Syndrome and Alström Syndrome
$MNKD -20.5% Update on Tyvaso DPI™ New Drug Application.
Highlights for next week
Multiple PDUFA target action dates: $CTIC, $AMYT, and $LEGN
Quarterly reports from companies with approved product:
$HRTX
$AUPH
$ENDP
$HRMY
$DVAX
$APLS
$ARDX
$OCUL
$SUPN
$AKBA
$HZNP
$JAZZ
$CMRX
$EPZM
$RYTM
$SRPT
$CCXI
$HCM
$EOLS
$PBYI
Watch over the next few weeks for quarterly company reports including commercial sales
See our Big Movers post to learn about the upcoming March Big Movers/Movers to Watch
Comments